Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,700 | -14,670 | -3,290 | -4,080 | -2,880 |
| Depreciation Amortization | -110 | 340 | 80 | 80 | 70 |
| Other Working Capital | -1,300 | -3,370 | -150 | 0 | -2,920 |
| Other Operating Activity | 190 | -710 | -140 | 180 | 10 |
| Operating Cash Flow | $-4,920 | $-18,410 | $-3,500 | $-3,820 | $-5,720 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 50 | -9 | 30 | 10 |
| Other Investing Activity | -2,430 | 8,690 | 5,509 | -1,850 | 8,500 |
| Investing Cash Flow | $-2,430 | $8,740 | $5,500 | $-1,820 | $8,510 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -7 | 21,850 | -20 | 8,100 | -2,290 |
| Financing Cash Flow | $-7 | $21,850 | $-20 | $8,100 | $-2,290 |
| Exchange Rate Effect | 10 | -140 | 130 | -290 | -10 |
| Beginning Cash Position | 18,370 | 6,580 | 9,010 | 6,810 | 5,630 |
| End Cash Position | 11,020 | 18,610 | 11,110 | 8,970 | 6,110 |
| Net Cash Flow | $-7,340 | $12,030 | $2,100 | $2,160 | $480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,920 | -18,410 | -3,500 | -3,820 | -5,720 |
| Free Cash Flow | -4,920 | -18,410 | -3,500 | -3,820 | -5,720 |